Report Open Access

Interventions for preventing and treating COVID-19: living systematic reviews and network meta-analyses

Isabelle Boutron; Anna Chaimani; Joerg J Meerpohl; Asbjørn Hróbjartsson; Declan Devane; Gabriel Rada; David Tovey; Giacomo Grasselli; Philippe Ravaud


DCAT Export

<?xml version='1.0' encoding='utf-8'?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:adms="http://www.w3.org/ns/adms#" xmlns:cnt="http://www.w3.org/2011/content#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" xmlns:dctype="http://purl.org/dc/dcmitype/" xmlns:dcat="http://www.w3.org/ns/dcat#" xmlns:duv="http://www.w3.org/ns/duv#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:frapo="http://purl.org/cerif/frapo/" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:gsp="http://www.opengis.net/ont/geosparql#" xmlns:locn="http://www.w3.org/ns/locn#" xmlns:org="http://www.w3.org/ns/org#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:prov="http://www.w3.org/ns/prov#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:vcard="http://www.w3.org/2006/vcard/ns#" xmlns:wdrs="http://www.w3.org/2007/05/powder-s#">
  <rdf:Description rdf:about="https://doi.org/10.5281/zenodo.4018607">
    <rdf:type rdf:resource="http://www.w3.org/ns/dcat#Dataset"/>
    <dct:type rdf:resource="http://purl.org/dc/dcmitype/Text"/>
    <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://doi.org/10.5281/zenodo.4018607</dct:identifier>
    <foaf:page rdf:resource="https://doi.org/10.5281/zenodo.4018607"/>
    <dct:creator>
      <rdf:Description rdf:about="http://orcid.org/0000-0002-5263-6241">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Isabelle Boutron</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Université de Paris, Inserm, Cochrane France, AP-HP, France</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description rdf:about="http://orcid.org/0000-0003-2828-6832">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Anna Chaimani</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Université de Paris, Inserm, Cochrane France, AP-HP, France</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description rdf:about="http://orcid.org/0000-0002-1333-5403">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Joerg J Meerpohl</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Institute for Evidence in Medicine, Medical Center &amp; Faculty of Medicine, University of Freiburg and Cochrane Germany, Cochrane Germany Foundation, Freiburg, Germany</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Asbjørn Hróbjartsson</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Centre for Evidence-Based Medicine Odense (CEBMO), University of Southern Denmark and Odense University Hospital, Denmark</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description rdf:about="http://orcid.org/0000-0002-9393-7075">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Declan Devane</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Evidence Synthesis Ireland &amp; Cochrane Ireland, National University of Ireland, Galway, Ireland</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Gabriel Rada</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Epistemonikos Foundation, UC Evidence Center, Cochrane Chile Associated Center, Pontificia Universidad Católica de Chile, Santiago, Chile</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>David Tovey</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Université de Paris, Inserm, Cochrane France, AP-HP, France</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Giacomo Grasselli</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Department of Anesthesia, Intensive Care and Emergency, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description rdf:about="http://orcid.org/0000-0001-8264-9206">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Philippe Ravaud</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Université de Paris, Inserm, Cochrane France, AP-HP, France</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:title>Interventions for preventing and treating COVID-19: living systematic reviews and network meta-analyses</dct:title>
    <dct:publisher>
      <foaf:Agent>
        <foaf:name>Zenodo</foaf:name>
      </foaf:Agent>
    </dct:publisher>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2020</dct:issued>
    <dcat:keyword>Covid-19</dcat:keyword>
    <dcat:keyword>2019-nCoV</dcat:keyword>
    <dcat:keyword>SARS-CoV-2</dcat:keyword>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2020-09-08</dct:issued>
    <dct:language rdf:resource="http://publications.europa.eu/resource/authority/language/ENG"/>
    <owl:sameAs rdf:resource="https://zenodo.org/record/4018607"/>
    <adms:identifier>
      <adms:Identifier>
        <skos:notation rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://zenodo.org/record/4018607</skos:notation>
      </adms:Identifier>
    </adms:identifier>
    <dct:isVersionOf rdf:resource="https://doi.org/10.5281/zenodo.3744599"/>
    <dct:isPartOf rdf:resource="https://zenodo.org/communities/covid-19"/>
    <dct:isPartOf rdf:resource="https://zenodo.org/communities/covid-nma"/>
    <dct:isPartOf rdf:resource="https://zenodo.org/communities/zenodo"/>
    <dct:description>&lt;p&gt;WHO declared COVID-19 a pandemic on March 11, 2020.&amp;nbsp;Researchers are working to accelerate the development of diagnostic tests, preventive interventions and therapeutic interventions. Many randomized trials have been established to evaluate candidate therapeutic agents that may effectively reduce symptoms and avoid deaths. This emerging situation requires the optimal planning and conduct of trials as well as strategies for the appropriate translation of research into practice. Therefore, decision-makers and researchers urgently need a complete, high-quality and up-to-date synthesis of data from all ongoing research studies as soon as they are available.&lt;/p&gt; &lt;p&gt;To this end, we will perform a living mapping of registered randomized trials and a living systematic review&amp;nbsp;with pairwise meta-analyses and when possible, network meta-analyses focusing on two main questions: 1) the effectiveness of preventive interventions for COVID-19 and 2) the effectiveness of treatment interventions for COVID-19. We will evaluate the impact of these treatments considering the severity of the disease (i.e., mild, moderate, severe and critical diseases).&lt;/p&gt; &lt;p&gt;This protocol details the process and methods we will use.&lt;/p&gt;</dct:description>
    <dct:accessRights rdf:resource="http://publications.europa.eu/resource/authority/access-right/PUBLIC"/>
    <dct:accessRights>
      <dct:RightsStatement rdf:about="info:eu-repo/semantics/openAccess">
        <rdfs:label>Open Access</rdfs:label>
      </dct:RightsStatement>
    </dct:accessRights>
    <dcat:distribution>
      <dcat:Distribution>
        <dct:rights>
          <dct:RightsStatement rdf:about="https://creativecommons.org/licenses/by/4.0/legalcode">
            <rdfs:label>Creative Commons Attribution 4.0 International</rdfs:label>
          </dct:RightsStatement>
        </dct:rights>
        <dcat:accessURL rdf:resource="https://doi.org/10.5281/zenodo.4018607"/>
      </dcat:Distribution>
    </dcat:distribution>
  </rdf:Description>
</rdf:RDF>
7,552
2,172
views
downloads
All versions This version
Views 7,5523,676
Downloads 2,17292
Data volume 2.8 GB7.2 MB
Unique views 6,9193,598
Unique downloads 1,88690

Share

Cite as